Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lello

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Endocrinological Investigation|November 21, 2018
Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGOL Vignozzi, N Malavolta, P Villa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2011
Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluationL Colonna, V Pacifico, S Lello, et al.
Climacteric : the Journal of the International Menopause Society|April 29, 2017
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?N Biglia, A Cagnacci, M Gambacciani, et al.
The American Journal of Clinical Nutrition|September 1, 2000
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancyH Valensise, A Andreoli, S Lello, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 26, 2020
Vitamin D supplementation: much ado about nothingD Gatti, F Bertoldo, G Adami, et al.
Minerva Ginecologica|September 21, 2004
[Duloxetine in the treatment of urinary incontinence in women]S Lello, A M Paoletti, F Guardianelli, et al.
Climacteric : the Journal of the International Menopause Society|November 13, 2009
LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopauseR E Nappi, S Lello, G Benedetto Melis, et al.
Fertility and Sterility|March 5, 1999
Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapyC Exacoustòs, S Lello, E Caporale, et al.
Minerva Ginecologica|June 13, 2008
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg]S Lello, G Primavera, L Colonna, et al.
Minerva Ginecologica|November 17, 2010
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism]S Lello, V Pacifico, G Primavera, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Endocrinological Investigation|November 21, 2018
Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGOL Vignozzi, N Malavolta, P Villa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2011
Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluationL Colonna, V Pacifico, S Lello, et al.
Climacteric : the Journal of the International Menopause Society|April 29, 2017
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?N Biglia, A Cagnacci, M Gambacciani, et al.
The American Journal of Clinical Nutrition|September 1, 2000
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancyH Valensise, A Andreoli, S Lello, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 26, 2020
Vitamin D supplementation: much ado about nothingD Gatti, F Bertoldo, G Adami, et al.
Minerva Ginecologica|September 21, 2004
[Duloxetine in the treatment of urinary incontinence in women]S Lello, A M Paoletti, F Guardianelli, et al.
Climacteric : the Journal of the International Menopause Society|November 13, 2009
LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopauseR E Nappi, S Lello, G Benedetto Melis, et al.
Fertility and Sterility|March 5, 1999
Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapyC Exacoustòs, S Lello, E Caporale, et al.
Minerva Ginecologica|June 13, 2008
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg]S Lello, G Primavera, L Colonna, et al.
Minerva Ginecologica|November 17, 2010
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism]S Lello, V Pacifico, G Primavera, et al.
Pageof 3